Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice

Qinyu Wang(Peking University), Rong Qi(Shihezi University)
British Journal of Pharmacology
November 23, 2019
Cited by 288


Related Papers